Bliddal H, Bays H, Czernichow S, Udden Hemmingsson J, Hjelmesaeth J, Hoffmann Morville T, Koroleva A, Skov Neergaard J, Velez Sanchez P, Wharton S, Wizert A, Kristensen LE, Group SS (2024) Once-weekly semaglutide in persons with obesity and knee osteoarthritis
Merchn WH, Gmez LA, Chasoy ME, Alfonso-Rodrguez CA, Muoz AL
The average person needs 8003,000 milligrams (mg) of lysine per day, depending on their individual needs
For more discussion of GLP-1 drugs , read Despite positive outcomes, coverage of GLP-1 drugs presents complicated questions, by HFMA senior editor Nick Hut
(Practice point) Once an SGLT2i is initiated, it is reasonable to continue an SGLT2i even if the eGFR falls below 30 ml/min per 1.73 m2, unless it is not tolerated or kidney replacement therapy is initiated.(Practice point) SGLT2i have not been adequately studied in kidney transplant recipients, who may benefit from SGLT2i treatment, but are immunosuppressed and potentially at increased risk for infections
Introduction Candida albicans ( C
